throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`_______________
`
`Case IPR2021-00880
`Patent No. 9,669,069 B2
`_______________
`
`PRO HAC VICE MOTION TO ADMIT VICTORIA REINES PURSUANT
`TO 37 C.F.R. § 42.10(c)
`
`1
`
`

`

`Case IPR2021-00880
`Patent No. 9,669,069 B2
`
`Pursuant to 37 C.F.R. § 42.10(c) Patent Owner Regeneron Pharmaceuticals,
`
`Inc. (“Patent Owner”) hereby files this motion for Ms. Victoria Reines to appear
`
`pro hac vice on its behalf before the Patent Trial and Appeal Board in this
`
`proceeding. As required by the Board’s Notice of Filing Date Accorded to Petition
`
`(Paper 3) this motion for pro hac vice admission under 37 C.F.R. § 42.10(c) is
`
`being “filed in accordance with the ‘Order -- Authorizing Motion for Pro Hac Vice
`
`Admission’ in Case IPR2013-00639” (“IPR2013-00639 Order”). (Paper 3 at 2.).
`
`Patent Owner conferred with Petitioner Mylan Pharmaceuticals Inc. (“Petitioner”)
`
`and Petitioner does not oppose the Motion for Admission pro hac vice.
`
`I.
`
`STATEMENT OF FACTS
`
`The following facts, along with the attached Declaration of Victoria
`
`Reines (Reines Decl.) support admission of Ms. Reines pro hac vice in this
`
`proceeding.
`
`1.
`
`Lead Counsel Deborah E. Fishman (Reg. No. 48,621) and Back-up
`
`Counsel Alice S. Ho (Lim. Rec. No. L1162) are the counsel of record for Patent
`
`Owner. Ms. Fishman and Ms. Ho are experienced patent attorneys and have
`
`worked closely with Ms. Reines since they became involved in these
`
`proceedings, and will continue to do so.
`
`2.
`
`Ms. Reines has significant familiarity with the subject matter in this
`
`proceeding and has substantive knowledge of the patent-at-issue (Patent No.
`
`2
`
`

`

`Case IPR2021-00880
`Patent No. 9,669,069 B2
`
`9,669,069 B2 (the “’069 Patent”)) by virtue of her preparation for this
`
`proceeding. (Reines Decl. ¶ 10). Ms. Reines has conducted a detailed review of
`
`the ‘069 Patent, the relevant prior art, and the prosecution history and related
`
`patents. In fact, a significant amount of Ms. Reines’ time since March 2020 has
`
`been spent working on issues related to the ’069 Patent and Patent Owner’s
`
`commercial product, Eylea®. Ms. Reines was substantively involved in the
`
`preparation of the Patent Owner Preliminary Response. Therefore, Ms. Reines
`
`has significant experience with the subject matter of this proceeding.
`
`II. REASONS FOR GRANTING THE MOTION
`
`The Board may recognize counsel pro hac vice during a proceeding “upon a
`
`showing of good cause, subject to the condition that lead counsel be a registered
`
`practitioner and to any other conditions as the Board may impose.” 37 C.F.R. §
`
`42.10(c). As set forth above, lead counsel in this proceeding, Deborah E. Fishman,
`
`is a registered practitioner. Moreover, as set forth above and in the accompanying
`
`Reines declaration, Ms. Reines is a patent litigation attorney and has an established
`
`familiarity with the subject matter at issue in the proceeding. (Reines Decl. ¶¶ 2,
`
`10).
`
`3
`
`

`

`Case IPR2021-00880
`Patent No. 9,669,069 B2
`
`III. CONCLUSION
`
`Because this motion and the accompanying declaration meet all of the
`
`Board’s requirements, Patent Owner respectfully requests that the Board admit Ms.
`
`Victoria Reines pro hac vice, in this proceeding.
`
`4
`
`

`

`Case IPR2021-00880
`Patent No. 9,669,069 B2
`
`Dated: November 22, 2021
`
`Respectfully submitted,
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`3000 El Camino Real,
`Five Palo Alto Square, Suite 500
`Palo Alto, CA 94306-3807
`
`Counsel for Patent Owner
`Regeneron Pharmaceuticals, Inc.
`
`5
`
`

`

`Case IPR2021-00880
`Patent No. 9,669,069 B2
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. §§ 42.6(e)(4)(i) et seq. and 42.105(b), the undersigned
`
`certifies that on November 22, 2021, a true and correct copy of this MOTION
`
`FOR PRO HAC VICE ADMISSION OF VICTORIA REINES was served via
`
`e-mail to the Patent Owner at the following email addresses:
`
`MYL_REG_IPR@rmmslegal.com
`paul@rmmslegal.com
`wrakoczy@rmmslegal.com
`hsalmen@rmmslegal.com
`nmclaughlin@rmmslegal.com
`
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`3000 El Camino Real,
`Five Palo Alto Square, Suite 500
`Palo Alto, CA 94306-3807
`
`Counsel for Patent Owner
`Regeneron Pharmaceuticals, Inc.
`
`-i-
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket